The Melvyn H Motolinsky Foundation proudly supports the Fellowship program directed by Dr. Claire Philipp. Under her guidance and with the use of the Motolinsky Research Laboratory, real progress is being made.
Leading the way towards advancements begins with the technology and facilities for doctors to strive in. The Melvyn H Motolinsky Laboratory for Hematology Research allows personnel to remain on the cutting edge of the search for a cure.
Medical progress requires patient, thorough, and dedicated work. Learn how remarkable strides in the fields of Hematology and Oncology have resulted in momentous breakthroughs that are saving lives.
Yetta and Ab Motolinsky created a living memorial for their lost son. With the help of their community, the vision of the Foundation and its purpose live on today. Board members including Nan (daughter) and Aran (grandson) continue the legacy of hope.
Today, Melvyn Motolinsky and countless thousands more like him could have a remission for years, and even a chance of cure, as medical science improves its knowledge, technology and treatment of leukemia. Achievements have not come easily, and so much more needs to be done.
On November 3rd, 2014 the Foundation honored Robert S. DiPaola, MD — Director of the Rutgers Cancer Institute of New Jersey.–Annual Distinguished Service Award
The Melvyn H. Motolinsky Laboratory for Hematology Research was established in 1972 in conjunction with the University of Medicine and Dentistry / Rutgers Medical School. The Laboratory has become an integral part of the Division of Hematology at the School and is widely recognized for its achievements. It is committed to research in all aspects of blood diseases based on the conviction that ultimately tragedies of blood disorders such as leukemia must and can be treated and cured.
In May 2014, Jack Borrus - treasurer of the Melvyn H. Motolinsky Research Foundation, was appointed chair of the board of directors of the Rutgers Robert Wood Johnson University Hospital Foundation of New Brunswick.